{"id":15066,"date":"2026-01-17T10:15:16","date_gmt":"2026-01-17T09:15:16","guid":{"rendered":"https:\/\/icoprevencio.cat\/uct\/2024-2\/"},"modified":"2026-01-17T10:15:16","modified_gmt":"2026-01-17T09:15:16","slug":"2024-2","status":"publish","type":"page","link":"https:\/\/icoprevencio.cat\/uct\/es\/2024-2\/","title":{"rendered":"2024"},"content":{"rendered":"\n
\n

Publicaciones<\/strong><\/strong><\/strong><\/h2><\/div><\/div><\/div><\/div>\n<\/div><\/div>\n
<\/a>
\r\n

2024<\/h3>

Carnicer-Pont D, Fu M, Castellano Y, Tigova O, Driezen P, Quah ACK, Kaai SC, Soriano JB, Vardavas CI, Fong GT, Fern\u00e1ndez E. <\/p>

Incidence and Determinants of COVID-19 Among People Who Smoke (2018-2021): Findings From the ITC EUREST-PLUS Spain Surveys<\/a>. Art\u00edculo<\/span> <\/p>

Arch Bronconeumol. <\/span>2024<\/span>;60<\/span>:690\u2013697<\/span>.<\/p>

Resumen<\/a><\/span> | Enlaces<\/a><\/span> | BibTeX<\/a><\/span> | Etiquetas: <\/span><\/p>

@article{pmid38944617,
\r\ntitle = {Incidence and Determinants of COVID-19 Among People Who Smoke (2018-2021): Findings From the ITC EUREST-PLUS Spain Surveys},
\r\nauthor = {Carnicer-Pont D and Fu M and Castellano Y and Tigova O and Driezen P and Quah ACK and Kaai SC and Soriano JB and Vardavas CI and Fong GT and Fern\u00e1ndez E},
\r\ndoi = {10.1016\/j.arbres.2024.05.037},
\r\nissn = {1579-2129},
\r\nyear  = {2024},
\r\ndate = {2024-11-01},
\r\njournal = {Arch Bronconeumol},
\r\nvolume = {60},
\r\nnumber = {11},
\r\npages = {690--697},
\r\nabstract = {OBJECTIVE: To estimate the cumulative incidence of COVID-19 and its determinants among a nationally representative sample of adults from Spain who smoke.nnMETHODS: This is a prospective cohort study that uses data from two waves (Wave 2 in 2018 and Wave 3 in 2021) of the ITC EUREST-PLUS Spain Survey. At baseline (Wave 1 in 2016), all respondents were adults (aged \u226518) who smoked. In total, 1008 respondents participated in Wave 2, and 570 out of 888 eligible participants were followed up in Wave 3 (64.2%). We estimated the cumulative incidence and the relative risk of COVID-19 (RR) and 95% confidence intervals (CI) during follow-up using self-reported information on sociodemographic, smoking-related and health-related characteristics and identified associated factors using multivariable Poisson models with robust variance adjusted for the independent variables.nnRESULTS: The overall cumulative incidence of self-reported COVID-19 was 5.9% (95% CI: 3.9-8.0%), with no significant differences between males (6.3%; 95% CI: 3.6-9.0%) and females (5.6%; 95% CI: 3.2-8.0%). After adjusting for age, sex, and educational level, COVID-19 incidence was positively associated with moderate nicotine dependence (RR: 2.37; 95% CI: 1.04-5.40) and negatively associated with having a partner who smoked (RR: 0.12; 95% CI: 0.03-0.42), and having friends but not a partner who smoked (RR: 0.28; 95% CI: 0.14-0.56).nnCONCLUSION: The correlates of having had COVID-19 among people who smoke should be considered when tailoring information and targeted non-pharmacological preventive measures.},
\r\nkeywords = {},
\r\npubstate = {published},
\r\ntppubtype = {article}
\r\n}
\r\n<\/pre><\/div>
Cerrar<\/a><\/p><\/div>
OBJECTIVE: To estimate the cumulative incidence of COVID-19 and its determinants among a nationally representative sample of adults from Spain who smoke.nnMETHODS: This is a prospective cohort study that uses data from two waves (Wave 2 in 2018 and Wave 3 in 2021) of the ITC EUREST-PLUS Spain Survey. At baseline (Wave 1 in 2016), all respondents were adults (aged \u226518) who smoked. In total, 1008 respondents participated in Wave 2, and 570 out of 888 eligible participants were followed up in Wave 3 (64.2%). We estimated the cumulative incidence and the relative risk of COVID-19 (RR) and 95% confidence intervals (CI) during follow-up using self-reported information on sociodemographic, smoking-related and health-related characteristics and identified associated factors using multivariable Poisson models with robust variance adjusted for the independent variables.nnRESULTS: The overall cumulative incidence of self-reported COVID-19 was 5.9% (95% CI: 3.9-8.0%), with no significant differences between males (6.3%; 95% CI: 3.6-9.0%) and females (5.6%; 95% CI: 3.2-8.0%). After adjusting for age, sex, and educational level, COVID-19 incidence was positively associated with moderate nicotine dependence (RR: 2.37; 95% CI: 1.04-5.40) and negatively associated with having a partner who smoked (RR: 0.12; 95% CI: 0.03-0.42), and having friends but not a partner who smoked (RR: 0.28; 95% CI: 0.14-0.56).nnCONCLUSION: The correlates of having had COVID-19 among people who smoke should be considered when tailoring information and targeted non-pharmacological preventive measures.<\/div>
Cerrar<\/a><\/p><\/div>